GSA Capital Partners’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Buy
29,626
+12,804
+76% +$52.5K 0.01% 1608
2026
Q1
$73K Buy
+16,822
New +$83.4K ﹤0.01% 1586
2025
Q4
Sell
-19,706
Closed -$75K 1896
2025
Q3
$75K Sell
19,706
-39,814
-67% -$152K 0.01% 1548
2025
Q2
$213K Buy
+59,520
New +$169K 0.01% 1478
2021
Q4
Sell
-50,690
Closed -$144K 1615
2021
Q3
$144K Buy
+50,690
New +$168K 0.01% 1288
2021
Q2
Sell
-176,734
Closed -$622K 1468
2021
Q1
$622K Buy
176,734
+92,839
+111% +$402K 0.1% 246
2020
Q4
$505K Buy
+83,895
New +$470K 0.08% 421

Other funds holding KRMD

GSA Capital Partners's KRMD Position: Q2 2026 in Review

GSA Capital Partners increased its KORU Medical Systems (KRMD) stake by 76% in Q2 2026, buying an estimated $52.5K and bringing the position to 29,626 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #1608.

GSA Capital Partners first reported a position in KRMD in Q4 2020 and has held it in 7 quarters since. The position peaked at $622K in Q1 2021. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • GSA Capital Partners held 29,626 shares of KORU Medical Systems worth $124K as of Q2 2026.
  • GSA Capital Partners bought 12,804 KORU Medical Systems shares in Q2 2026, an estimated $52.5K.
  • KORU Medical Systems made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1608 holding.
  • GSA Capital Partners first reported a position in KORU Medical Systems in Q4 2020 and has held it in 7 quarters since.
  • GSA Capital Partners's KORU Medical Systems position peaked at $622K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.